Will Smith

@willpjsmith.bsky.social

I love science! I study toxin interactions in microbes. Dad of two @wellcometrust Sir Henry Wellcome Fellow | All views my own | he/him | 🏳️‍🌈 Lab website: https://willsmithlab.com/

Eye-opening work by @olimeacock.bsky.social (former postdoc, now PI in Sheffield). He presents an exact mapping from steady-state consumer-resource to generalized Lotka-Volterra models, revealing that cross-feeding can lead to competition for other limiting resources. Feedback pls!

Oliver Meacock@olimeacock.bsky.social · 2mo ago

New preprint from @saramitri.bsky.social and me: tinyurl.com/3dsjnm4d The headline result - we derive a general way to connect mechanistic ecosystem models to the gLV equation. This reveals that strengthening cooperative mechanisms can make effective gLV interactions increasingly competitive. Weird!

It's funny how we stigmatize being wrong in science. There's nothing better in science than being wrong and getting to change your mind about something. Any day you were wrong is a day you get to learn something new!

How does treatment induced antibiotic resistance happen in real-world infections? We analysed 25k Pseudomonas isolates from 180 patients in a clinical trial to find out! TLDR: The ecological and evolutionary paths are surprisingly diverse & complex even in patients receiving identical treatment…

Matthew J Shepherd@matthewjshepherd.bsky.social · 6mo ago

🚨 New pre-print! 🚨 In the largest study of its kind to-date, we investigate the ecological and evolutionary mechanisms driving within-patient evolution of antimicrobial resistance (AMR). Read here: www.biorxiv.org/content/10.6... , and follow along with this thread, discussing our findings (1/21)

New preprint! Ever wondered why only a fraction of genomes encode CRISPR immunity? 🧬 🦠 Turns out CRISPR is rarely beneficial against virulent phages, being most beneficial against those for which resistance mutations are rare! An epic effort by Rosanna Wright www.biorxiv.org/content/10.1...

Resistance mutation supply modulates the benefit of CRISPR immunity against virulent phages

Only a fraction of bacterial genomes encode CRISPR-Cas systems but the selective causes of this variation are unexplained. How naturally virulent bacteriophages (phages) select for CRISPR immunity has...

biorxiv.org